{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:08:59Z","timestamp":1789625339926,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004423","name":"WHO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Vector Borne Disease Control Programme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lymphatic filariasis (LF) is a significant public health issue in India. Despite 10\u201315 rounds of mass drug administration (MDA) in India, the global LF elimination target of 2030 appears challenging. To strengthen the program, community and provider perspectives on ways to bridge a gap in MDA are needed. Through the motivation\u2013opportunity\u2013ability\u2013behaviour (MOAB) lens, we systematically reviewed the facilitators and barriers encountered in LF elimination in India. We followed Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. We searched PubMed, Embase, ProQuest and Google Scholar databases to explore factors related to MDA program implementation in India through 30 June 2021. We analysed the data using a thematic framework. We identified 576 studies; of these, 20 studies were included. This review revealed that the public health system for distributing MDA drugs in India created a better enabling environment, including zero out-of-pocket expenditure, door-step distribution of medicines and ample capacity-building training and follow-up. However, community members were unaware of the rationale for drug consumption, leading to a gap in drug distribution and consumption. Motivation is required among community members, which suggests capacity-building training for service providers to counsel the community.<\/jats:p>","DOI":"10.1093\/trstmh\/trae008","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T12:14:56Z","timestamp":1710936896000},"page":"426-435","source":"Crossref","is-referenced-by-count":4,"title":["Motivation\u2013opportunity\u2013ability\u2013behaviour of community members and program implementers towards mass drug administration for lymphatic filariasis elimination in India: a systematic review and implementation priority"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-3671","authenticated-orcid":false,"given":"Abhinav","family":"Sinha","sequence":"first","affiliation":[{"name":"Health Technology Assessment in India, Regional Resource Hub, ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumegha","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krushna Chandra","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Health Technology Assessment in India, Regional Resource Hub, ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhashisha","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Joint Director of Health Services, National Vector Borne Disease Control Programme, Department of Health and Family Welfare, Government of Odisha , Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banamber","family":"Sahoo","sequence":"additional","affiliation":[{"name":"ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Pati","sequence":"additional","affiliation":[{"name":"Health Technology Assessment in India, Regional Resource Hub, ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"ICMR\u2013Regional Medical Research Centre , Bhubaneswar \u00a0 751023, Odisha , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"2024070511015312800_bib1","first-page":"73","article-title":"The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals","volume-title":"Infect Dis Poverty","author":"Bangert","year":"2017"},{"issue":"1","key":"2024070511015312800_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/tropicalmed3010004","article-title":"Mosquitoes and the lymphatic filarial parasites: research trends and budding roadmaps to future disease eradication","volume":"3","author":"Famakinde","year":"2018","journal-title":"Trop Med Infect Dis"},{"issue":"6","key":"2024070511015312800_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2471\/BLT.06.031047","article-title":"Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature","volume":"85","author":"Wynd","year":"2007","journal-title":"Bull World Health Org"},{"issue":"2","key":"2024070511015312800_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00436-020-06991-y","article-title":"Lymphatic filariasis in Asia: a systematic review and meta-analysis","volume":"120","author":"Bizhani","year":"2021","journal-title":"Parasitol Res"},{"issue":"11","key":"2024070511015312800_bib5","doi-asserted-by":"crossref","first-page":"e2570","DOI":"10.1371\/journal.pntd.0002570","article-title":"NTDs V. 2.0: \u201cblue marble health\u201d\u2014neglected tropical disease control and elimination in a shifting health policy landscape","volume":"7","author":"Hotez","year":"2013","journal-title":"PLoS NeglTrop Dis"},{"issue":"3","key":"2024070511015312800_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/tropicalmed2030032","article-title":"Lymphatic filariasis in mainland Southeast Asia: a systematic review and meta-analysis of prevalence and disease burden","volume":"2","author":"Dickson","year":"2017","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"2024070511015312800_bib7","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1080\/21645515.2021.1989925","article-title":"Investigating immunological interaction between lymphatic filariasis and COVID-19 infection: a preliminary evidence","volume":"17","author":"Sinha","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"2024070511015312800_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/00494755221098532","article-title":"Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: a step towards achieving SDG-3","volume":"52","author":"Sinha","year":"2022","journal-title":"Trop Doct"},{"issue":"10","key":"2024070511015312800_bib9","first-page":"673","article-title":"Elimination of lymphatic filariasis in India\u2014a successful endeavour","volume":"106","author":"Srivastava","year":"2008","journal-title":"J Indian Med Assoc"},{"issue":"1","key":"2024070511015312800_bib10","doi-asserted-by":"crossref","first-page":"e001334","DOI":"10.1136\/bmjgh-2018-001334","article-title":"Neglected tropical diseases and the sustainable development goals: an urgent call for action from the front line","volume":"4","author":"Addisu","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2024070511015312800_bib11","article-title":"Elimination of lymphatic filariasis","author":"National Center for Vector Borne Diseases Control (NCVBDC)"},{"issue":"9","key":"2024070511015312800_bib12","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1016\/S2214-109X(20)30286-2","article-title":"The global distribution of lymphatic filariasis, 2000\u201318: a geospatial analysis","volume":"8","author":"Cromwell","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"9","key":"2024070511015312800_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/trstmh\/tru057","article-title":"Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review","volume":"108","author":"Babu","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2024070511015312800_bib14","first-page":"89","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume-title":"Syst Rev","author":"Page","year":"2021"},{"issue":"7","key":"2024070511015312800_bib15","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4103\/jfmpc.jfmpc_1243_21","article-title":"Facilitators and barriers in implementation of mass drug administration for lymphatic filariasis elimination in India: a protocol for systematic review and qualitative meta-synthesis","volume":"11","author":"Sinha","year":"2022","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"2024070511015312800_bib16","first-page":"31","article-title":"Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis","volume":"1","author":"Long","year":"2020","journal-title":"Res Methods Med Health Sci"},{"issue":"2","key":"2024070511015312800_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/004947550303300208","article-title":"Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India","volume":"33","author":"Babu","year":"2003","journal-title":"Trop Doct"},{"issue":"6","key":"2024070511015312800_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"Babu","year":"2004","journal-title":"Trop Med Int Health"},{"issue":"7","key":"2024070511015312800_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1179\/000349804225021433","article-title":"The programme to eliminate lymphatic filariasis in Orissa, India: the attitudes of some programme partners","volume":"98","author":"Babu","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"issue":"12","key":"2024070511015312800_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","article-title":"Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance","volume":"102","author":"Babu","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2024070511015312800_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1995-7645(10)60033-8","article-title":"A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa, India","volume":"3","author":"Babu","year":"2010","journal-title":"Asian Pac J Trop Med"},{"issue":"9","key":"2024070511015312800_bib22","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4103\/jfmpc.jfmpc_503_19","article-title":"Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: a mixed method study","volume":"8","author":"Banerjee","year":"2019","journal-title":"J Family Med Prim Care"},{"issue":"9","key":"2024070511015312800_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.9790\/0853-1509056568","article-title":"Glimpses of MDA compliance survey in North 24 PGNS of West Bengal","volume":"15","author":"Basu","year":"2016","journal-title":"IOSR J Dent Med Sci"},{"issue":"Suppl 2014","key":"2024070511015312800_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21276\/apjhs.2014.1.1s.14","article-title":"A quantitative and qualitative evaluation of mass drug administration (MDA) program in three districts of Madhya Pradesh (India)","volume":"1","author":"Bhatia","year":"2014","journal-title":"Asian Pac J Health Sci"},{"issue":"3","key":"2024070511015312800_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.47203\/IJCH.2018.v30i03.017","article-title":"Mass drug administration (MDA) for elimination of lymphatic filariasis: experiences from Nayagarh District of Odisha, India","volume":"30","author":"Bhatia","year":"2018","journal-title":"Indian J Community Health"},{"issue":"1","key":"2024070511015312800_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/2229-5070.149921","article-title":"Is the coverage of mass-drug-administration adequate for elimination of Bancroftian filariasis? An experience from West Bengal","volume":"5","author":"Haldar","year":"2015","journal-title":"India Trop Parasitol"},{"key":"2024070511015312800_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-9957-3-31","article-title":"Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance","volume":"3","author":"Hussain","year":"2014","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2024070511015312800_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1010539508327032","article-title":"Clinicians\u2019 attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India","volume":"21","author":"Kerketta","year":"2009","journal-title":"Asia Pac J Public Health"},{"issue":"4","key":"2024070511015312800_bib29","first-page":"313","article-title":"Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study","volume":"45","author":"Lahariya","year":"2008","journal-title":"J Vector Borne Dis"},{"issue":"3","key":"2024070511015312800_bib30","first-page":"300","article-title":"Bridging the gap in outreach and compliance with mass drug administration for lymphatic filariasis elimination in an endemic district in Kerala, India: an intervention research approach","volume":"34","author":"Nandha","year":"2019","journal-title":"Health Educ Res"},{"issue":"1","key":"2024070511015312800_bib31","first-page":"23","article-title":"Evaluation of coverage and compliance to mass drug administration (MDA) for lymphatic filariasis elimination\u2014a qualitative study","volume":"1","author":"Nujum","year":"2013","journal-title":"Acad Med J India"},{"issue":"3","key":"2024070511015312800_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/2394-7438.166306","article-title":"Mass drug administration program against lymphatic filariasis: are we on the path to success? Experience from Solapur District, Maharashtra","volume":"1","author":"Parande","year":"2015","journal-title":"MAMC J Med Sci"},{"issue":"5","key":"2024070511015312800_bib33","first-page":"10","article-title":"Coverage evaluation survey of mass drug administration for lymphatic filariasis in Purbabarddhaman District, West Bengal","volume":"17","author":"Paul","year":"2018","journal-title":"IOSR J Dent Med Sci"},{"issue":"12","key":"2024070511015312800_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-3156.2000.00659.x","article-title":"A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects","volume":"5","author":"Ramaiah","year":"2000","journal-title":"Trop Med Int Health"},{"issue":"2","key":"2024070511015312800_bib35","first-page":"156","article-title":"Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India","volume":"23","author":"Rath","year":"2006","journal-title":"Trop Biomed"},{"issue":"2","key":"2024070511015312800_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3329\/jhpn.v31i2.16380","article-title":"Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India","volume":"31","author":"Roy","year":"2013","journal-title":"J Health Popul Nutr"},{"issue":"11","key":"2024070511015312800_bib37","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"19","key":"2024070511015312800_bib38","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.3390\/ijerph191912971","article-title":"Factors associated with the acceptability of mass drug administration for filariasis: a systematic review","volume":"19","author":"Abdul Halim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2024070511015312800_bib39","first-page":"CD013638","article-title":"Community views on mass drug administration for filariasis: a qualitative evidence synthesis","author":"Taylor","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024070511015312800_bib40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12889-017-4414-5","article-title":"A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa","volume":"17","author":"Silumbwe","year":"2017","journal-title":"BMC Public Health"},{"issue":"6","key":"2024070511015312800_bib41","doi-asserted-by":"crossref","first-page":"e0006426","DOI":"10.1371\/journal.pntd.0006426","article-title":"Ensuring no one is left behind: urgent action required to address implementation challenges for NTD control and elimination","volume":"12","author":"Krentel","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2024070511015312800_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13012-016-0538-8","article-title":"Behavior change interventions and policies influencing primary healthcare professionals\u2019 practice\u2014an overview of reviews","volume":"12","author":"Chauhan","year":"2017","journal-title":"Implement Sci"},{"issue":"12","key":"2024070511015312800_bib43","doi-asserted-by":"crossref","first-page":"e031666","DOI":"10.1136\/bmjopen-2019-031666","article-title":"Community health workers involvement in preventative care in primary healthcare: a systematic scoping review","volume":"9","author":"Sharma","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"2024070511015312800_bib44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.socscimed.2012.03.016","article-title":"Behaviour change communication targeting four health behaviours in developing countries: a review of change techniques","volume":"75","author":"Briscoe","year":"2012","journal-title":"Soc Sci Med"},{"key":"2024070511015312800_bib45","article-title":"Everybody's business\u2014strengthening health systems to improve health outcomes: WHO's framework for action","author":"World Health Organization","year":"2007"},{"key":"2024070511015312800_bib46","article-title":"Social determinants of health","author":"World Health Organization","year":"2008"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/118\/7\/426\/58448993\/trae008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/118\/7\/426\/58448993\/trae008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:02:29Z","timestamp":1720177349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/118\/7\/426\/7632344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,3,20]]},"published-print":{"date-parts":[[2024,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trae008","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,20]]}}}